31.00
+0.06(+0.19%)
Currency In HKD
Address
No. 108, Meiliang Road
Wuxi, 214092
China
Phone
86 51081831205
Sector
Healthcare
Industry
Biotechnology
Employees
12575
First IPO Date
June 13, 2017
| Name | Title | Pay | Year Born |
| Dr. Zhisheng Chen Ph.D. | Chief Executive Officer & Executive Director | 9,213 | 1973 |
| Dr. Weichang Zhou Ph.D. | Honorary President of Global Biologics Development, Senior Advisor to Chief Executive Officer & Non-Executive Director | 4.48M | 1964 |
| Ms. Li Xiong | Vice President & Head of Global Human Resources | 0 | N/A |
| Mr. Ming Tu | Chief Financial Officer & Executive Vice President | 0 | 1969 |
| Dr. Jijie Gu Ph.D. | Chief Scientific Officer & President of Global Biologics Research | 0 | 1966 |
| Dr. Ge Li Ph.D. | Founder & Chairman | 0 | 1967 |
| Lihua Yu M.B.A. | Chief Operating Officer & Senior Vice President | 0 | N/A |
| Dr. Sherry Gu Ph.D. | Chief Technology Officer & Executive Vice President of Global Biologics Development Department | 0 | 1971 |
| Ms. Lina Fan Ph.D. | Senior Vice President & Head of Investor Relations | 0 | N/A |
| He Wang | General Counsel, Chief Compliance Officer, SVice President and Head of Legal,Compliance & Risk Management Center | 0 | N/A |
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.